NTBL
Vascular Biogenics Ltd

6,977
Loading...
Loading...
News
all
press releases
News Placeholder
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion...
PR Newswire·1y ago
News Placeholder
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
FOSTER CITY, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) ( Notable , Notable Labs ), a clinical-stage therapeutics platform company developing a new class of...
Globe Newswire·2y ago
News Placeholder
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment
Predictive Precision Medicine Platform (PPMP) utilized to enrich program for clinically responding patients and reduce the risk, time, and cost of drug developmentVolasertib Phase 2 trial initiation...
Globe Newswire·2y ago

Latest NTBL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.